Skip to main content

Hematological Changes with Aging

  • Chapter
  • First Online:
Geriatric Trauma and Critical Care

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  1. MacKenzie E, Fowler C. Epidemiology. In: Feliciano D, Moore E, Mattox K, editors. Trauma. 6th ed. New York: McGraw-Hill; 1996. p. 26–32.

    Google Scholar 

  2. Kannus P, Parkkari J, Koskinen S, Niemi S, Palvanen M, Jarvinen M, et al. Fall-induced injuries and deaths among older adults. JAMA. 1999;281(20):1895–9.

    Article  CAS  PubMed  Google Scholar 

  3. Alexander BH, Rivara FP, Wolf ME. The cost and frequency of hospitalization for fall-related injuries in older adults. Am J Public Health. 1992;82(7):1020–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Guillamondegui O, Seesholtz RE, Booker L, Love T. Trauma care in Tennessee: 2014 report to the 108th general assembly. Nashville: State of Tennessee Department of Health; 2014.

    Google Scholar 

  5. Hill RD. The prevalence of anaemia in the over-65s in a rural practice. Practitioner. 1976;217(1302):963–7.

    CAS  PubMed  Google Scholar 

  6. Myers AM, Saunders CR, Chalmers DG. The haemoglobin level of fit elderly people. Lancet. 1968;2(7562):261–3.

    Article  CAS  PubMed  Google Scholar 

  7. McLennan WJ, Andrews GR, Macleod C, Caird FI. Anaemia in the elderly. Q J Med. 1973;42(165):1–13.

    CAS  PubMed  Google Scholar 

  8. Gershoff SN, Brusis OA, Nino HV, Huber AM. Studies of the elderly in Boston. I. The effects of iron fortification on moderately anemic people. Am J Clin Nutr. 1977;30(2):226–34.

    CAS  PubMed  Google Scholar 

  9. Lipschitz DA, Udupa KB, Milton KY, Thompson CO. Effect of age on hematopoiesis in man. Blood. 1984;63(3):502–9.

    CAS  PubMed  Google Scholar 

  10. Ershler WB, Sheng S, McKelvey J, Artz AS, Denduluri N, Tecson J, et al. Serum erythropoietin and aging: a longitudinal analysis. J Am Geriatr Soc. 2005;53(8):1360–5.

    Article  PubMed  Google Scholar 

  11. Brightwell RF, Crawford GP, Cale JB, Pedler PJ, Bittles AH. Ageing and the haematological profiles of an Australian community. Ann Hum Biol. 1998;25(1):1–10.

    Article  CAS  PubMed  Google Scholar 

  12. Deschler B, Lubbert M. Acute myeloid leukemia: epidemiology and etiology. Cancer. 2006;107(9):2099–107.

    Article  PubMed  Google Scholar 

  13. Hotta T, Hirabayashi N, Utsumi M, Murate T, Yamada H. Age-related changes in the function of hemopoietic stroma in mice. Exp Hematol. 1980;8(7):933–6.

    CAS  PubMed  Google Scholar 

  14. Harrison DE. Long-term erythropoietic repopulating ability of old, young, and fetal stem cells. J Exp Med. 1983;157(5):1496–504.

    Article  CAS  PubMed  Google Scholar 

  15. Gross L. Mechanisms of aging in bone marrow stem cells. PLoS Biol. 2007;5(8):e215.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Woolthuis CM, de Haan G, Huls G. Aging of hematopoietic stem cells: intrinsic changes or micro-environmental effects? Curr Opin Immunol. 2011;23(4):512–7.

    Article  CAS  PubMed  Google Scholar 

  17. Pinto A, De Filippi R, Frigeri F, Corazzelli G, Normanno N. Aging and the hemopoietic system. Crit Rev Oncol Hematol. 2003;48(Suppl):S3–S12.

    Article  PubMed  Google Scholar 

  18. Balducci L, Lyman GH. Patients aged > or = 70 are at high risk for neutropenic infection and should receive hemopoietic growth factors when treated with moderately toxic chemotherapy. J Clin Oncol. 2001;19(5):1583–5.

    Article  CAS  PubMed  Google Scholar 

  19. Gaynor ER, Dahlberg S, Fisher RI. Factors affecting reduced survival of the elderly with intermediate and high-grade lymphoma: an analysis of SWOG-8516 (INT 0067). Proc Am Soc Clin Oncol. 1994;13:370.

    Google Scholar 

  20. Boggs DR, Patrene KD. Hematopoiesis and aging III: anemia and a blunted erythropoietic response to hemorrhage in aged mice. Am J Hematol. 1985;19(4):327–38.

    Article  CAS  PubMed  Google Scholar 

  21. Wu WC, Schifftner TL, Henderson WG, Eaton CB, Poses RM, Uttley G, et al. Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery. JAMA. 2007;297(22):2481–8.

    Article  CAS  PubMed  Google Scholar 

  22. Gearhart MM, Luchette FA, Proctor MC, Lutomski DM, Witsken C, James L, et al. The risk assessment profile score identifies trauma patients at risk for deep vein thrombosis. Surgery. 2000;128(4):631–40.

    Article  CAS  PubMed  Google Scholar 

  23. Tracy RP, Bovill EG. Thrombosis and cardiovascular risk in the elderly. Arch Pathol Lab Med. 1992;116(12):1307–12.

    CAS  PubMed  Google Scholar 

  24. Bauer KA, Weiss LM, Sparrow D, Vokonas PS, Rosenberg RD. Aging-associated changes in indices of thrombin generation and protein C activation in humans. Normative Aging Study. J Clin Invest. 1987;80(6):1527–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Balleisen L, Bailey J, Epping PH, Schulte H, van de Loo J. Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population: I. Baseline data on the relation to age, gender, body-weight, smoking, alcohol, pill-using, and menopause. Thromb Haemost. 1985;54(2):475–9.

    CAS  PubMed  Google Scholar 

  26. Mari D, Mannucci PM, Coppola R, Bottasso B, Bauer KA, Rosenberg RD. Hypercoagulability in centenarians: the paradox of successful aging. Blood. 1995;85(11):3144–9.

    CAS  PubMed  Google Scholar 

  27. Sagripanti A, Carpi A. Natural anticoagulants, aging, and thromboembolism. Exp Gerontol. 1998;33(7–8):891–6.

    Article  CAS  PubMed  Google Scholar 

  28. Sakkinen PA, Cushman M, Psaty BM, Kuller LH, Bajaj SP, Sabharwal AK, et al. Correlates of antithrombin, protein C, protein S, and TFPI in a healthy elderly cohort. Thromb Haemost. 1998;80(1):134–9.

    CAS  PubMed  Google Scholar 

  29. Zahavi J, Jones NA, Leyton J, Dubiel M, Kakkar VV. Enhanced in vivo platelet "release reaction" in old healthy individuals. Thromb Res. 1980;17(3–4):329–36.

    Article  CAS  PubMed  Google Scholar 

  30. Modesti PA, Fortini A, Abbate R, Gensini GF. Age related changes of platelet prostacyclin receptors in humans. Eur J Clin Invest. 1985;15(4):204–8.

    Article  CAS  PubMed  Google Scholar 

  31. Bastyr 3rd EJ, Kadrofske MM, Vinik AI. Platelet activity and phosphoinositide turnover increase with advancing age. Am J Med. 1990;88(6):601–6.

    Article  CAS  PubMed  Google Scholar 

  32. Conlan MG, Folsom AR, Finch A, Davis CE, Sorlie P, Marcucci G, et al. Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost. 1993;70(3):380–5.

    CAS  PubMed  Google Scholar 

  33. Abbate R, Prisco D, Rostagno C, Boddi M, Gensini GF. Age-related changes in the hemostatic system. Int J Clin Lab Res. 1993;23(1):1–3.

    Article  CAS  PubMed  Google Scholar 

  34. Yamamoto K, Takeshita K, Kojima T, Takamatsu J, Saito H. Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: implication in the pathogenesis of thrombotic disorders in the elderly. Cardiovasc Res. 2005;66(2):276–85.

    Article  CAS  PubMed  Google Scholar 

  35. Yamamoto K, Takeshita K, Shimokawa T, Yi H, Isobe K, Loskutoff DJ, et al. Plasminogen activator inhibitor-1 is a major stress-regulated gene: implications for stress-induced thrombosis in aged individuals. Proc Natl Acad Sci U S A. 2002;99(2):890–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Konkle BA, Schuster SJ, Kelly MD, Harjes K, Hassett DE, Bohrer M, et al. Plasminogen activator inhibitor-1 messenger RNA expression is induced in rat hepatocytes in vivo by dexamethasone. Blood. 1992;79(10):2636–42.

    CAS  PubMed  Google Scholar 

  37. Yamamoto K, Loskutoff DJ. Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator. J Clin Invest. 1996;97(11):2440–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Pignone M, Anderson GK, Binns K, Tilson HH, Weisman SM. Aspirin use among adults aged 40 and older in the United States: results of a national survey. Am J Prev Med. 2007;32(5):403–7.

    Article  PubMed  Google Scholar 

  39. Clinton P, Mozeson M. The Pharm Exec 50 May 2010 [cited 2012 August 1]. Available from: http://images.alfresco.advanstar.com/alfresco_images/pharma/2014/08/21/80187efe-d7d7-45af-b045-c9e8e7184141/article-671415.pdf.

  40. Ohm C, Mina A, Howells G, Bair H, Bendick P. Effects of antiplatelet agents on outcomes for elderly patients with traumatic intracranial hemorrhage. J Trauma. 2005;58(3):518–22.

    Article  CAS  PubMed  Google Scholar 

  41. Ivascu FA, Howells GA, Junn FS, Bair HA, Bendick PJ, Janczyk RJ. Predictors of mortality in trauma patients with intracranial hemorrhage on preinjury aspirin or clopidogrel. J Trauma. 2008;65(4):785–8.

    Article  CAS  PubMed  Google Scholar 

  42. Thiele T, Sumnig A, Hron G, Muller C, Althaus K, Schroeder HW, et al. Platelet transfusion for reversal of dual antiplatelet therapy in patients requiring urgent surgery: a pilot study. J Thromb Haemost. 2012;10(5):968–71.

    Article  CAS  PubMed  Google Scholar 

  43. Martin AC, Berndt C, Calmette L, Philip I, Decouture B, Gaussem P, et al. The effectiveness of platelet supplementation for the reversal of ticagrelor-induced inhibition of platelet aggregation: an in-vitro study. Eur J Anaesthesiol. 2016;33(5):361–7.

    Article  CAS  PubMed  Google Scholar 

  44. Ranucci M, Nano G, Pazzaglia A, Bianchi P, Casana R, Tealdi DG. Platelet mapping and desmopressin reversal of platelet inhibition during emergency carotid endarterectomy. J Cardiothorac Vasc Anesth. 2007;21(6):851–4.

    Article  PubMed  Google Scholar 

  45. Bansal V, Fortlage D, Lee J, Doucet J, Potenza B, Coimbra R. A new clopidogrel (Plavix) point-of-care assay: rapid determination of antiplatelet activity in trauma patients. J Trauma. 2011;70(1):65–9; discussion 9–70.

    Google Scholar 

  46. Bachelani AM, Bautz JT, Sperry JL, Corcos A, Zenati M, Billiar TR, et al. Assessment of platelet transfusion for reversal of aspirin after traumatic brain injury. Surgery. 2011;150(4):836–43.

    Article  PubMed  Google Scholar 

  47. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med. 1995;155(5):469–73.

    Article  CAS  PubMed  Google Scholar 

  48. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285(18):2370–5.

    Article  CAS  PubMed  Google Scholar 

  49. Ageno W, Gallus AS, Wittkowsky A, Crowther M, Hylek EM, Palareti G, et al. Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e44S–88S.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Mina AA, Bair HA, Howells GA, Bendick PJ. Complications of preinjury warfarin use in the trauma patient. J Trauma. 2003;54(5):842–7.

    Article  PubMed  Google Scholar 

  51. Pabinger I, Brenner B, Kalina U, Knaub S, Nagy A, Ostermann H, et al. Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial. J Thromb Haemost. 2008;6(4):622–31.

    Article  CAS  PubMed  Google Scholar 

  52. Sarode R, Milling Jr TJ, Refaai MA, Mangione A, Schneider A, Durn BL, et al. Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study. Circulation. 2013;128(11):1234–43.

    CAS  PubMed  Google Scholar 

  53. Goldstein JN, Refaai MA, Milling Jr TJ, Lewis B, Goldberg-Alberts R, Hug BA, et al. Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. Lancet. 2015;385(9982):2077–87.

    Article  CAS  PubMed  Google Scholar 

  54. DeLoughery TG. Practical aspects of the oral new anticoagulants. Am J Hematol. 2011;86(7):586–90.

    Article  CAS  PubMed  Google Scholar 

  55. Furie KL, Goldstein LB, Albers GW, Khatri P, Neyens R, Turakhia MP, et al. Oral antithrombotic agents for the prevention of stroke in nonvalvular atrial fibrillation: a science advisory for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2012;43(12):3442–53.

    Article  PubMed  Google Scholar 

  56. Eerenberg ES, Kamphuisen PW, Sijpkens MK, Meijers JC, Buller HR, Levi M. Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. Circulation. 2011;124(14):1573–9.

    Article  CAS  PubMed  Google Scholar 

  57. Pollack Jr CV, Reilly PA, Eikelboom J, Glund S, Verhamme P, Bernstein RA, et al. Idarucizumab for dabigatran reversal. N Engl J Med. 2015;373(6):511–20.

    Article  CAS  PubMed  Google Scholar 

  58. Siegal DM, Curnutte JT, Connolly SJ, Lu G, Conley PB, Wiens BL, et al. Andexanet alfa for the reversal of factor Xa inhibitor activity. N Engl J Med. 2015;373:2413–24.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Martin A. Schreiber MD, FACS .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Fischer, P.E., DeLoughery, T.G., Gesin, G., Schreiber, M.A. (2017). Hematological Changes with Aging. In: Luchette, F., Yelon, J. (eds) Geriatric Trauma and Critical Care. Springer, Cham. https://doi.org/10.1007/978-3-319-48687-1_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-48687-1_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-48685-7

  • Online ISBN: 978-3-319-48687-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics